Theranos's Investors: Were They Duped or Did They Make a Bad Bet?
WSJ Tech News Briefing - A podcast by The Wall Street Journal
A key question in the criminal fraud trial of Theranos founder Elizabeth Holmes relates to the defunct blood-testing startup's investors: Were they deceived or did they just make an unwise bet? Reporter Heather Somerville joins host Zoe Thomas to discuss how the prosecution and defense will use the knowledge and experience of Theranos's investors to make their cases. Learn more about your ad choices. Visit megaphone.fm/adchoices
